Top

14-04-2025 | Human Papillomavirus | Review Article

Patient and healthcare provider factors influencing shared clinical decision-making for HPV (human papillomavirus) vaccination among adults aged 27–45 years old in the United States: a systematic review

Authors: Tanjila Taskin, Idara N. Akpan, Grace Maynard, Sarah A. Alkhatib, Christopher W. Wheldon, Jessica Grace, Erika L. Thompson

Published in: Journal of Public Health

Abstract

Aim

The United States Advisory Committee on Immunization Practices (ACIP) recommended shared clinical decision-making for mid-adult HPV vaccination. However, healthcare practitioners and patients struggle with shared clinical decision-making (SCDM) due to unclear guidelines. The purpose of this systematic review was to identify factors contributing to decision-making for HPV vaccination among US mid-adults aged 27 - 45 and factors that influence healthcare providers implementing this guideline.

Methods

Following PRISMA guidelines, PubMed, PsycINFO, SCOPUS, and the Web of Science were searched for peer-reviewed articles published in English between 2006 and 2022. Fourteen articles were included in this review. The Anderson’s healthcare utilization model was used to synthesize the results into predisposing, enabling, and need-based factors.

Results

The predisposing factors that positively influenced HPV vaccination were being male, having a graduate degree, and having HPV knowledge. Enabling factors that positively influenced HPV vaccination were having health insurance, healthcare provider recommendations, access to health care services, a trusted source for information, financial support, and emotional support. Need-based factors that positively influenced HPV vaccination were perceived cancer risk, prior HPV infection, reducing HPV-related morbidities, and improving physical health. Healthcare providers were more likely to recommend the vaccine if they were aware of the ACIP guideline, and for patients who were younger, in a relationship, or had more than one sexual partner, had health insurance, and had a history of high-grade HPV infection.

Conclusion

The review suggests routine provider training and developing patient decision-aid tools to facilitate the shared clinical decision-making process for increasing HPV vaccination in this age group.

Andersen RM (1995) Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav 36(1):1–10CrossRefPubMed

Andersen R, Newman JF (1973) Societal and individual determinants of medical care utilization in the United States. The Milbank Memorial Fund quarterly. Health Soc 51(1):95–124

Cartmell KB, Young-Pierce J, McGue S, Alberg AJ, Luque JS, Zubizarreta M, Brandt HM (2018) Barriers, facilitators, and potential strategies for increasing HPV vaccination: a statewide assessment to inform action. Papillomavirus Res (Amsterdam, Netherlands) 5:21–31. https://doi.org/10.1016/j.pvr.2017.11.003CrossRef

Centers for Disease Control and Prevention (2016) Questions answered on vaccines purchased with 317 funds. Available from: https://www.cdc.gov/vaccines/imz-managers/guides-pubs/qa-317-funds.html

Centers for Disease Control and Prevention (2022) How many cancers are linked with HPV each year? Available from: https://www.cdc.gov/cancer/hpv/statistics/cases.htm

Cernasev A, Hohmeier KC, Oyedeji O, Hagemann T, Kintziger KW, Wisdom T, Gatwood J (2023) perspectives associated with human Papillomavirus vaccination in adults: a qualitative study. Vaccines 11(4):850CrossRefPubMedPubMedCentral

Galvin AM, Garg A, Moore JD, Litt DM, Thompson EL (2021) Quality over quantity: human papillomavirus vaccine information on social media and associations with adult and child vaccination. Human Vacc Immunother 17(10):3587–3594. https://doi.org/10.1080/21645515.2021.1932219CrossRef

Galvin AM, Garg A, Griner SB, Moore JD, Thompson EL (2023) Health literacy correlates to HPV vaccination among US adults ages 27–45. J Cancer Educ 38(1):349–356. https://doi.org/10.1007/s13187-021-02123-xCrossRefPubMed

Harrison R, Jones B, Gardner P, Lawton R (2021) Quality assessment with diverse studies (QuADS): an appraisal tool for methodological and reporting quality in systematic reviews of mixed- or multi-method studies. BMC Health Services Res 21(1):144. https://doi.org/10.1186/s12913-021-06122-yCrossRef

Head KJ, Biederman E, Sturm LA, Zimet GD (2018) A retrospective and prospective look at strategies to increase adolescent HPV vaccine uptake in the United States. Human Vacc Immunother 14(7):1626–1635CrossRef

Hubka TA, Wisner KP, Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (2011) Vaccinations recommended during pregnancy and breastfeeding. J Am Osteopath Assoc 111(10 Suppl 6):S23–S30PubMed

Hurley LP, O’Leary ST, Markowitz LE, Crane LA, Cataldi JR, Brtnikova M, Beaty BL, Gorman C, Meites E, Lindley MC, Kempe A (2021) US primary care physicians’ viewpoints on HPV vaccination for adults 27 to 45 Years. J Am Board Fam Med 34(1):162–170CrossRefPubMed

Kasting ML, Giuliano AR, Christy SM, Rouse CE, Robertson SE, Thompson EL (2020) Human Papillomavirus vaccination prevalence among adults aged 19–45 years: an analysis of the 2017 national health interview survey. Am J Prevent Med 59(6):837–849. https://doi.org/10.1016/j.amepre.2020.05.031CrossRef

Kasting ML, Head KJ, DeMaria AL, Neuman MK, Russell AL, Robertson SE, Rouse CE, Zimet GD (2021) A national survey of obstetrician/gynecologists’ knowledge, attitudes, and beliefs regarding adult human papillomavirus vaccination. J Women’s Health (2002) 30(10):1476–1484CrossRef

Koskan A, Brennhofer SA, Helitzer D (2020) Administering the HPV vaccine to people living with HIV: providers’ perspectives. J Prim Prevent 41(4):349–362. https://doi.org/10.1007/s10935-020-00598-wCrossRef

Lake PW, Head KJ, Christy SM, DeMaria AL, Thompson EL, Vadaparampil ST, Zimet GD, Kasting ML (2022) Association between patient characteristics and HPV vaccination recommendation for postpartum patients: a national survey of Obstetrician/Gynecologists. Prevent Med Rep 27:101801CrossRef

Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE (2019) Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 68(32):698–702. https://doi.org/10.15585/mmwr.mm6832a3CrossRefPubMedPubMedCentral

Muthukrishnan M, Loux T, Shacham E, Tiro JA, Arnold LD (2022) Barriers to human papillomavirus (HPV) vaccination among young adults, aged 18–35. Prevent Med Rep 29:101942. https://doi.org/10.1016/j.pmedr.2022.101942CrossRef

Pingali C, Yankey D, Elam-Evans LD, Markowitz LE, Valier MR, Fredua B, Crowe SJ, DeSisto CL, Stokley S, Singleton JA (2023) Vaccination coverage among adolescents aged 13–17 Years - National Immunization Survey-Teen, United States, 2022. MMWR Morb Mortal Wkly Rep 72(34):912–919CrossRefPubMedPubMedCentral

Polonijo AN, Mahapatra D, Brown B (2022) “I thought it was just for teenagers”: knowledge, attitudes, and beliefs about hpv vaccination among women aged 27 to 45. Women’s Health Issues : Off Publ Jacobs Instit Women’s Health 32(3):301–308. https://doi.org/10.1016/j.whi.2022.01.007CrossRef

Reiter PL, Bustamante G, McRee AL (2020) HPV vaccine coverage and acceptability among a national sample of sexual minority women ages 18–45. Vaccine 38(32):4956–4963. https://doi.org/10.1016/j.vaccine.2020.06.001CrossRefPubMedPubMedCentral

Ryan G, Avdic L, Daly E, Askelson N, Farris PE, Shannon J, McRee AL, Hanson J, Kenyon DB, Seegmiller L (2021) Influences on HPV vaccination across levels of the social ecological model: perspectives from state level stakeholders. Human Vacci Immunother 17(4):1006–1013CrossRef

Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MC, Su J, Xu F, Weinstock H (2013) Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis 40(3):187–193. https://doi.org/10.1097/OLQ.0b013e318286bb53CrossRefPubMed

Schroeder SA (2007) Shattuck Lecture. We can do better–improving the health of the American people. New England J Med 357(12):1221–1228CrossRef

Senkomago V, Henley SJ, Thomas CC, Mix JM, Markowitz LE, Saraiya M (2019) Human papillomavirus-attributable cancers - United States, 2012–2016. MMWR Morb Mortal Wkly Rep 68(33):724–728CrossRefPubMedPubMedCentral

Sirriyeh R, Lawton R, Gardner P, Armitage G (2012) Reviewing studies with diverse designs: the development and evaluation of a new tool. J Eval Clin Pract 18(4):746–752. https://doi.org/10.1111/j.1365-2753.2011.01662.xCrossRefPubMed

Thompson EL, Garg A, Galvin AM, Moore JD, Kasting ML, Wheldon CW (2021) Correlates of HPV vaccination intentions among adults ages 27–45 years old in the U.S. J Commun Health 46(5):893–902CrossRef

Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, …, Straus SE (2018) PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Int Med 169(7):467–473.

US Food & Drug Administration (2018) FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-expanded-use-gardasil-9-include-individuals-27-through-45-years-old

Veritas Health Innovation (2019) Covidence systematic review software. Melbourne, Australia. Available at www.covidence.org

Wheldon CW, Maness SB (2021) An Assessment of cancer education needs to promote mid-adult HPV vaccination among male sexual minorities. J Cancer Educ 36(2):401–405. https://doi.org/10.1007/s13187-019-01644-wCrossRefPubMed

Wheldon CW, Garg A, Galvin AM, Moore JD, Thompson EL (2021) Decision support needs for shared clinical decision-making regarding HPV vaccination among adults 27–45 years of age. Patient Educ Couns 104(12):3079–3085CrossRefPubMed

Wheldon CW, Eaton LA, Watson RJ (2023) Predisposing, enabling, and need-related factors associated with human Papillomavirus vaccination intentions and uptake among black and hispanic sexual and gender diverse adults in the USA. J Rac Ethn Health Disparities 10(1):237–243CrossRef

Williams WW, Lu PJ, Saraiya M, Yankey D, Dorell C, Rodriguez JL, Kepka D, Markowitz LE (2013) Factors associated with human papillomavirus vaccination among young adult women in the United States. Vaccine 31(28):2937–2946CrossRefPubMedPubMedCentral

Title: Patient and healthcare provider factors influencing shared clinical decision-making for HPV (human papillomavirus) vaccination among adults aged 27–45 years old in the United States: a systematic review
Authors: Tanjila Taskin
Idara N. Akpan
Grace Maynard
Sarah A. Alkhatib
Christopher W. Wheldon
Jessica Grace
Erika L. Thompson
Publication date: 14-04-2025
Publisher: Springer Berlin Heidelberg
Keywords: Human Papillomavirus
Vaccination
Published in: Journal of Public Health
Print ISSN: 2198-1833
Electronic ISSN: 1613-2238
DOI: https://doi.org/10.1007/s10389-025-02462-9

Navigating neuroimaging in Alzheimer disease care

Springer Medicine

Patient and healthcare provider factors influencing shared clinical decision-making for HPV (human papillomavirus) vaccination among adults aged 27–45 years old in the United States: a systematic review

Abstract

Aim

Methods

Results

Conclusion

Navigating neuroimaging in Alzheimer disease care

Springer Medicine

Abstract

Aim

Methods

Results

Conclusion

Please log in to get access to this content